Ben Davidson

Publications published since 1995 or in press by Ben Davidson

220 publications found

Publications in press

1. Benraiss A, Bruel-Jungerman E, Lu G, Economides AN, Davidson B, Goldman SA
   Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF
   Gene Ther (in press)
   PubMed 21918547
2. Benraiss A, Bruel-Jungerman E, Lu G, Economides AN, Davidson B, Goldman SA
   Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF
   Gene Ther (in press)
   PubMed 22071975
3. Bock AJ, Nymoen DA, Brenne K, Kærn J, Davidson B
   SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions
   Hum Pathol (in press)
   PubMed 21855113
4. Brenne K, Nymoen DA, Hetland TE, Trope' CG, Davidson B
   Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival
   Hum Pathol (in press)
   PubMed 21855111
5. Brusegard K, Stavnes HT, Nymoen DA, Flatmark K, Trope CG, Davidson B
   Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma
   Virchows Arch (in press)
   PubMed 22249560
6. Davidson B, Stavnes HT, Risberg B, Nesland JM, Wohlschlaeger J, Yang Y, Shih IM, Wang TL
   Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions
   Hum Pathol (in press)
   PubMed 21937081
7. Elstrand MB, Sandstad B, Oksefjell H, Davidson B, Tropé CG
   Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective
   Acta Obstet Gynecol Scand (in press)
   PubMed 22050605
8. Elstrand MB, Stavnes HT, Tropé CG, Davidson B
   Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions
   Hum Pathol (in press)
   PubMed 21864883
9. Hetland TE, Kærn J, Skrede M, Sandstad B, Tropé C, Davidson B, Flørenes VA
   Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index
   Cancer Chemother Pharmacol (in press)
   PubMed 22302409
10. Kim G, Davidson B, Henning R, Wang J, Yu M, Annunziata C, Hetland T, Kohn EC
    Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome
    Cancer (in press)
    PubMed 22009736

Publications 2012

1. Bock AJ, Dong HP, Tropé CG, Staff AC, Risberg B, Davidson B (2012)
   Nucleoside transporters are widely expressed in ovarian carcinoma effusions
   Cancer Chemother Pharmacol, 69 (2), 467-75
   PubMed 21822668
2. Brenne K, Nymoen DA, Reich R, Davidson B (2012)
   PRAME (Preferentially Expressed Antigen of Melanoma) Is a Novel Marker for Differentiating Serous Carcinoma From Malignant Mesothelioma
   Am J Clin Pathol, 137 (2), 240-7
   PubMed 22261449
3. Venkatesh B, Davidson B, Robinson K, Pascoe R, Appleton C, Jones M (2012)
   Do random estimations of vitamin D3 and parathyroid hormone reflect the 24-h profile in the critically ill?
   Intensive Care Med, 38 (1), 177-9
   PubMed 22113816

Publications 2011

1. Bock AJ, Tuft Stavnes H, Kærn J, Berner A, Staff AC, Davidson B (2011)
   Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
   Tumour Biol, 32 (3), 589-96
   PubMed 21350924
2. Davidson B (2011)
   The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma
   Cytopathology, 22 (1), 5-21
   PubMed 21114695
3. Davidson B, Holth A, Moripen L, Trope' CG, Shih IeM (2011)
   Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome
   Hum Pathol, 42 (7), 991-7
   PubMed 21315424
4. Davidson B, Stavnes HT, Holth A, Chen X, Yang Y, Shih IeM, Wang TL (2011)
   Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
   J Cell Mol Med, 15 (3), 535-44
   PubMed 20132413
5. Dong HP, Holth A, Ruud MG, Emilsen E, Risberg B, Davidson B (2011)
   Measurement of apoptosis in cytological specimens by flow cytometry: comparison of Annexin V, caspase cleavage and dUTP incorporation assays
   Cytopathology, 22 (6), 365-72
   PubMed 21054589
6. Dong HP, Ree Rosnes AK, Bock AJ, Holth A, Flørenes VA, Trope' CG, Risberg B, Davidson B (2011)
   Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusions
   Cytopathology, 22 (6), 373-82
   PubMed 22032542
7. Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, Vora MI, Patel C, Orina JN, Eliseeva TA, Singal V, Padmanabhan R, Davidson B, Ganapathi R, Sood AK, Rueda BR, Ambudkar SV, Gottesman MM (2011)
   Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
   Proc Natl Acad Sci U S A, 108 (46), 18708-13
   PubMed 22068913
8. Gillet JP, Wang J, Calcagno AM, Green LJ, Varma S, Bunkholt Elstrand M, Trope CG, Ambudkar SV, Davidson B, Gottesman MM (2011)
   Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions
   Mol Pharm, 8 (6), 2080-8
   PubMed 21761824
9. Hetland TE, Hellesylt E, Flørenes VA, Tropé C, Davidson B, Kærn J (2011)
   Class III ?-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance
   Hum Pathol, 42 (7), 1019-26
   PubMed 21315408
10. Hoskins E, Rodriguez-Canales J, Hewitt SM, Elmasri W, Han J, Han S, Davidson B, Kohn EC (2011)
    Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells
    Gynecol Oncol, 122 (3), 656-62
    PubMed 21676452
11. Reich R, Hadar S, Davidson B (2011)
    Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma
    Int J Mol Sci, 12 (2), 1133-45
    PubMed 21541048
12. Safdar N, McKinley LM, Davidson B, Broome C, Schenk J (2011)
    Recommendations to replace peripheral venous catheters every 72-96 hours: is a single reference enough?
    J Hosp Infect, 79 (2), 172-3
    PubMed 21802173
13. Schmitt F, Cochand-Priollet B, Toetsch M, Davidson B, Bondi A, Vielh P (2011)
    Immunocytochemistry in Europe: results of the European Federation of Cytology Societies (EFCS) inquiry
    Cytopathology, 22 (4), 238-42
    PubMed 21771093
14. Vaksman O, Stavnes HT, Kaern J, Trope CG, Davidson B, Reich R (2011)
    miRNA profiling along tumour progression in ovarian carcinoma
    J Cell Mol Med, 15 (7), 1593-602
    PubMed 20716115
15. Wang TL, Davidson B, Buckhaults PJ, Huang CS, Poul G (2011)
    Molecular genetic markers in female reproductive cancers
    J Oncol, 2010, 307460
    PubMed 21541207
16. Yuan Y, Dong HP, Nymoen DA, Nesland JM, Wu C, Davidson B (2011)
    PINCH-2 expression in cancers involving serosal effusions using quantitative PCR
    Cytopathology, 22 (1), 22-9
    PubMed 20500520
17. Yuan Y, Leszczynska M, Konstantinovsky S, Tropé CG, Reich R, Davidson B (2011)
    Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors
    Diagn Cytopathol, 39 (8), 562-6
    PubMed 20730893

Publications 2010

1. Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC (2010)
   Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer
   Cancer, 116 (13), 3276-84
   PubMed 20564628
2. Bock AJ, Stavnes HT, Kempf T, Tropè CG, Berner A, Davidson B, Staff AC (2010)
   Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions
   Int J Gynecol Cancer, 20 (9), 1448-55
   PubMed 21336029
3. Bunkholt Elstrand M, Dong HP, Ødegaard E, Holth A, Elloul S, Reich R, Tropé CG, Davidson B (2010)
   Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma
   Hum Pathol, 41 (6), 794-804
   PubMed 20153512
4. Davidson B, Reich R, Trope CG, Wang TL, Shih IeM (2010)
   New determinates of disease progression and outcome in metastatic ovarian carcinoma
   Histol Histopathol, 25 (12), 1591-609
   PubMed 20886439
5. Davidson B, Stavnes HT, Førsund M, Berner A, Staff AC (2010)
   CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival
   Breast, 19 (6), 493-8
   PubMed 21078485
6. Elloul S, Vaksman O, Stavnes HT, Trope CG, Davidson B, Reich R (2010)
   Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions
   Clin Exp Metastasis, 27 (3), 161-72
   PubMed 20213325
7. Flatmark K, Davidson B, Kristian A, Stavnes HT, Førsund M, Reed W (2010)
   Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
   Hum Pathol, 41 (8), 1109-19
   PubMed 20338618
8. Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM (2010)
   Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer
   Cancer Res, 70 (10), 4005-14
   PubMed 20424119
9. Jinawath N, Vasoontara C, Jinawath A, Fang X, Zhao K, Yap KL, Guo T, Lee CS, Wang W, Balgley BM, Davidson B, Wang TL, Shih IeM (2010)
   Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma
   PLoS One, 5 (6), e11198
   PubMed 20585448
10. Micci F, Haugom L, Ahlquist T, Andersen HK, Abeler VM, Davidson B, Trope CG, Lothe RA, Heim S (2010)
    Genomic aberrations in borderline ovarian tumors
    J Transl Med, 8, 21
    PubMed 20184781
11. Oy GF, Slipicevic A, Davidson B, Solberg Faye R, Maelandsmo GM, Flørenes VA (2010)
    Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma
    Int J Cancer, 126 (2), 350-61
    PubMed 19588500
12. Park JT, Chen X, Tropè CG, Davidson B, Shih IeM, Wang TL (2010)
    Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin
    Am J Pathol, 177 (3), 1087-94
    PubMed 20671266
13. Pradhan M, Abeler VM, Davidson B, Kildal W, Nybøen A, Tropé CG, Risberg B, Danielsen HE (2010)
    DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens
    Int J Gynecol Pathol, 29 (6), 572-8
    PubMed 20881853
14. Shih IeM, Chen L, Wang CC, Gu J, Davidson B, Cope L, Kurman RJ, Xuan J, Wang TL (2010)
    Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis
    Am J Obstet Gynecol, 203 (6), 584.e1-22
    PubMed 20965493
15. Staff AC, Bock AJ, Becker C, Kempf T, Wollert KC, Davidson B (2010)
    Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer
    Gynecol Oncol, 118 (3), 237-43
    PubMed 20576287
16. Ueda SM, Yap KL, Davidson B, Tian Y, Murthy V, Wang TL, Visvanathan K, Kuhajda FP, Bristow RE, Zhang H, Shih IeM (2010)
    Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas
    J Oncol, 2010, 285191
    PubMed 20508725
17. Yu GQ, Feng YJ, Miller DJ, Xuan JH, Hoffman EP, Clarke R, Davidson B, Shih IM, Wang Y (2010)
    Matched Gene Selection and Committee Classifier for Molecular Classification of Heterogeneous Diseases
    J. Mach. Learn. Res., 11, 2141-2167

Publications 2009

1. Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R (2009)
   Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival
   Hum Pathol, 40 (5), 705-13
   PubMed 19157507
2. Dong HP, Holth A, Kleinberg L, Ruud MG, Elstrand MB, Tropé CG, Davidson B, Risberg B (2009)
   Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters
   Am J Clin Pathol, 132 (5), 756-62
   PubMed 19846818
3. Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B (2009)
   Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma
   Int J Gynecol Pathol, 28 (3), 211-21
   PubMed 19620938
4. Kleinberg L, Davidson B (2009)
   Cell survival and apoptosis-related molecules in cancer cells in effusions: a comprehensive review
   Diagn Cytopathol, 37 (8), 613-24
   PubMed 19418469
5. Kleinberg L, Dong HP, Holth A, Risberg B, Trope' CG, Nesland JM, Flørenes VA, Davidson B (2009)
   Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma
   Hum Pathol, 40 (6), 795-806
   PubMed 19157506
6. Konstantinovsky S, Smith Y, Zilber S, Tuft Stavnes H, Becker AM, Nesland JM, Reich R, Davidson B (2009)
   Breast carcinoma cells in primary tumors and effusions have different gene array profiles
   J Oncol, 2010, 969084
   PubMed 19680458
7. Maelandsmo GM, Flørenes VA, Nguyen MT, Flatmark K, Davidson B (2009)
   Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites
   Tumour Biol, 30 (1), 15-25
   PubMed 19194111
8. Pradhan M, Davidson B, Tropé CG, Danielsen HE, Abeler VM, Risberg B (2009)
   Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas--an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications
   Virchows Arch, 454 (6), 677-83
   PubMed 19421773
9. Pretorius ME, Waehre H, Abeler VM, Davidson B, Vlatkovic L, Lothe RA, Giercksky KE, Danielsen HE (2009)
   Large scale genomic instability as an additive prognostic marker in early prostate cancer
   Cell Oncol, 31 (4), 251-9
   PubMed 19633362
10. Sebban S, Davidson B, Reich R (2009)
    Lysyl oxidase-like 4 is alternatively spliced in an anatomic site-specific manner in tumors involving the serosal cavities
    Virchows Arch, 454 (1), 71-9
    PubMed 19015874
11. Shih IeM, Davidson B (2009)
    Pathogenesis of ovarian cancer: clues from selected overexpressed genes
    Future Oncol, 5 (10), 1641-57
    PubMed 20001801
12. Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B (2009)
    Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions
    Hum Pathol, 40 (4), 527-37
    PubMed 19121847
13. Tropé C, Davidson B, Paulsen T, Abeler VM, Kaern J (2009)
    Diagnosis and treatment of borderline ovarian neoplasms "the state of the art"
    Eur J Gynaecol Oncol, 30 (5), 471-82
    PubMed 19899396
14. Virador VM, Davidson B, Czechowicz J, Mai A, Kassis J, Kohn EC (2009)
    The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome
    PLoS One, 4 (4), e5136
    PubMed 19352495
15. Yuan Y, Nymoen DA, Dong HP, Bjørang O, Shih IeM, Low PS, Trope' CG, Davidson B (2009)
    Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
    Hum Pathol, 40 (10), 1453-60
    PubMed 19454358
16. Yuan Y, Nymoen DA, Stavnes HT, Rosnes AK, Bjørang O, Wu C, Nesland JM, Davidson B (2009)
    Tenascin-X is a novel diagnostic marker of malignant mesothelioma
    Am J Surg Pathol, 33 (11), 1673-82
    PubMed 19738457

Publications 2008

1. Choi JH, Park JT, Davidson B, Morin PJ, Shih IeM, Wang TL (2008)
   Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion
   Cancer Res, 68 (14), 5716-23
   PubMed 18632624
2. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih IeM, Zhang Y, Wood W, Becker KG, Morin PJ (2008)
   MicroRNA expression and identification of putative miRNA targets in ovarian cancer
   PLoS One, 3 (6), e2436
   PubMed 18560586
3. Davidson B (2008)
   New diagnostic and molecular characteristics of malignant mesothelioma
   Ultrastruct Pathol, 32 (6), 227-40
   PubMed 19117264
4. Davidson B, Dong HP, Holth A, Berner A, Risberg B (2008)
   The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions
   Breast J, 14 (5), 476-82
   PubMed 18657145
5. Davidson B, Hadar R, Schlossberg A, Sternlicht T, Slipicevic A, Skrede M, Risberg B, Flørenes VA, Kopolovic J, Reich R (2008)
   Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma
   Hum Pathol, 39 (1), 87-95
   PubMed 17949781
6. Davidson B, Shih IeM, Wang TL (2008)
   Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma
   Hum Pathol, 39 (11), 1630-6
   PubMed 18656238
7. Davidson B, Wang TL, Shih IeM, Berner A (2008)
   Expression of the chromatin remodeling factor Rsf-1 is down-regulated in breast carcinoma effusions
   Hum Pathol, 39 (4), 616-22
   PubMed 18289639
8. Dong HP, Kleinberg L, Davidson B, Risberg B (2008)
   Methods for simultaneous measurement of apoptosis and cell surface phenotype of epithelial cells in effusions by flow cytometry
   Nat Protoc, 3 (6), 955-64
   PubMed 18546596
9. Dong HP, Kleinberg L, Silins I, Flørenes VA, Tropé CG, Risberg B, Nesland JM, Davidson B (2008)
   Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma
   Cancer, 112 (1), 84-93
   PubMed 17985388
10. Gilliam AD, Davidson B, Guest J (2008)
    The carbon footprint of laparoscopic surgery: should we offset?
    Surg Endosc, 22 (2), 573
    PubMed 18095020
11. Kleinberg L, Holth A, Trope CG, Reich R, Davidson B (2008)
    Claudin upregulation in ovarian carcinoma effusions is associated with poor survival
    Hum Pathol, 39 (5), 747-57
    PubMed 18439941
12. Kleinberg L, Pradhan M, Tropé CG, Nesland JM, Davidson B, Risberg B (2008)
    Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors
    Diagn Cytopathol, 36 (9), 637-44
    PubMed 18677760
13. Rayhman O, Klipper E, Muller L, Davidson B, Reich R, Meidan R (2008)
    Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells
    Cancer Res, 68 (22), 9265-73
    PubMed 19010899
14. Slipicevic A, Jørgensen K, Skrede M, Rosnes AK, Trøen G, Davidson B, Flørenes VA (2008)
    The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells
    BMC Cancer, 8, 276
    PubMed 18826602
15. Ødegaard E, Davidson B, Elgaaen BV, Fagerhol MK, Engh V, Onsrud M, Staff AC (2008)
    Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary
    Am J Obstet Gynecol, 198 (4), 418.e1-7
    PubMed 18241816
16. Ødegaard E, Davidson B, Engh V, Onsrud M, Staff AC (2008)
    Assessment of endoglin and calprotectin as potential biomarkers in ovarian carcinoma and borderline tumors of the ovary
    Am J Obstet Gynecol, 199 (5), 533.e1-8
    PubMed 18533117

Publications 2007

1. Annunziata CM, Kleinberg L, Davidson B, Berner A, Gius D, Tchabo N, Steinberg SM, Kohn EC (2007)
   BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer
   Clin Cancer Res, 13 (22 Pt 1), 6585-92
   PubMed 18006758
2. Davidson B (2007)
   Anatomic site-related expression of cancer-associated molecules in ovarian carcinoma
   Curr Cancer Drug Targets, 7 (1), 109-20
   PubMed 17305482
3. Davidson B (2007)
   Biological characteristics of cancers involving the serosal cavities
   Crit Rev Oncog, 13 (3), 189-227
   PubMed 18298385
4. Davidson B (2007)
   Expression of cancer-associated molecules in malignant mesothelioma
   Biomark Insights, 2, 173-84
   PubMed 19662202
5. Davidson B, Baekelandt M, Shih IeM (2007)
   MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells
   Diagn Cytopathol, 35 (12), 756-60
   PubMed 18008338
6. Davidson B, Berner A, Trope' CG, Wang TL, Shih IeM (2007)
   Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions
   Hum Pathol, 38 (7), 1030-6
   PubMed 17391728
7. Davidson B, Dong HP, Holth A, Berner A, Risberg B (2007)
   Chemokine receptors are infrequently expressed in malignant and benign mesothelial cells
   Am J Clin Pathol, 127 (5), 752-9
   PubMed 17439834
8. Davidson B, Dong HP, Holth A, Berner A, Risberg B (2007)
   Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applications
   Diagn Cytopathol, 35 (9), 568-78
   PubMed 17703449
9. Davidson B, Shafat I, Risberg B, Ilan N, Trope' CG, Vlodavsky I, Reich R (2007)
   Heparanase expression correlates with poor survival in metastatic ovarian carcinoma
   Gynecol Oncol, 104 (2), 311-9
   PubMed 17030350
10. Davidson B, Skrede M, Silins I, Shih IeM, Trope CG, Flørenes VA (2007)
    Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma
    Cancer, 110 (6), 1264-71
    PubMed 17647260
11. Davidson B, Xi Z, Saatcioglu F (2007)
    Kallikrein 4 is expressed in malignant mesothelioma--further evidence for the histogenetic link between mesothelial and epithelial cells
    Diagn Cytopathol, 35 (2), 80-4
    PubMed 17230566
12. Dong HP, Holth A, Berner A, Davidson B, Risberg B (2007)
    Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls
    Cytometry B Clin Cytom, 72 (5), 332-43
    PubMed 17226863
13. Gotlieb WH, Bruchim I, Ben-Baruch G, Davidson B, Zeltser A, Andersen A, Olsen H (2007)
    Doxorubicin levels in the serum and ascites of patients with ovarian cancer
    Eur J Surg Oncol, 33 (2), 213-5
    PubMed 17174514
14. Kleinberg L, Flørenes VA, Nesland JM, Davidson B (2007)
    Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions
    Am J Clin Pathol, 128 (3), 389-97
    PubMed 17709312
15. Kleinberg L, Flørenes VA, Silins I, Haug K, Trope CG, Nesland JM, Davidson B (2007)
    Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma
    Cancer, 109 (2), 228-38
    PubMed 17167759
16. Kleinberg L, Holth A, Fridman E, Schwartz I, Shih IeM, Davidson B (2007)
    The diagnostic role of claudins in serous effusions
    Am J Clin Pathol, 127 (6), 928-37
    PubMed 17509990
17. Kleinberg L, Lie AK, Flørenes VA, Nesland JM, Davidson B (2007)
    Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma
    Hum Pathol, 38 (7), 986-94
    PubMed 17350081
18. Salani R, Davidson B, Fiegl M, Marth C, Müller-Holzner E, Gastl G, Huang HY, Hsiao JC, Lin HS, Wang TL, Lin BL, Shih IeM (2007)
    Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions
    Clin Cancer Res, 13 (19), 5805-9
    PubMed 17908972
19. Sudbo J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Soland TM, Lippman SM (2007)
    Molecular based treatment of oral cancer (Retraction of vol 39, pg 749, 2003)
    Oral Oncol., 43 (4), 421
20. Ødegaard E, Staff AC, Abeler VM, Kopolovic J, Onsrud M, Lazarovici P, Davidson B (2007)
    The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma
    Hum Pathol, 38 (1), 140-6
    PubMed 16996570

Publications 2006

1. Bassarova AV, Nesland JM, Davidson B (2006)
   D2-40 is not a specific marker for cells of mesothelial origin in serous effusions
   Am J Surg Pathol, 30 (7), 878-82
   PubMed 16819331
2. Berner A, Sigstad E, Pradhan M, Grøholt KK, Davidson B (2006)
   Fine-needle aspiration cytology of the thyroid gland: comparative analysis of experience at three hospitals
   Diagn Cytopathol, 34 (2), 97-100
   PubMed 16514672
3. Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC (2006)
   Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling
   Clin Cancer Res, 12 (3 Pt 1), 791-9
   PubMed 16467090
4. Davidson B, Konstantinovsky S, Kleinberg L, Nguyen MT, Bassarova A, Kvalheim G, Nesland JM, Reich R (2006)
   The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma
   Gynecol Oncol, 102 (3), 453-61
   PubMed 16494928
5. Davidson B, Risberg B, Berner A, Bedrossian CW, Reich R (2006)
   The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma
   Semin Diagn Pathol, 23 (1), 35-43
   PubMed 17044194
6. Davidson B, Trope' CG, Wang TL, Shih IeM (2006)
   Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival
   Gynecol Oncol, 103 (3), 814-9
   PubMed 16844205
7. Davidson B, Zhang Z, Kleinberg L, Li M, Flørenes VA, Wang TL, Shih IeM (2006)
   Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma
   Clin Cancer Res, 12 (20 Pt 1), 5944-50
   PubMed 17062665
8. Dong HP, Elstrand MB, Holth A, Silins I, Berner A, Trope CG, Davidson B, Risberg B (2006)
   NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma
   Am J Clin Pathol, 125 (3), 451-8
   PubMed 16613351
9. Elloul S, Silins I, Tropé CG, Benshushan A, Davidson B, Reich R (2006)
   Expression of E-cadherin transcriptional regulators in ovarian carcinoma
   Virchows Arch, 449 (5), 520-8
   PubMed 17024425
10. Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R (2006)
    The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma
    Gynecol Oncol, 103 (3), 831-40
    PubMed 16919315
11. Jørgensen K, Davidson B, Flørenes VA (2006)
    Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma
    Mod Pathol, 19 (11), 1446-55
    PubMed 16951673
12. Kleinberg L, Flørenes VA, Skrede M, Dong HP, Nielsen S, McMaster MT, Nesland JM, Shih IeM, Davidson B (2006)
    Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma
    Virchows Arch, 449 (1), 31-9
    PubMed 16541284
13. Nakayama K, Nakayama N, Davidson B, Katabuchi H, Kurman RJ, Velculescu VE, Shih IeM, Wang TL (2006)
    Homozygous deletion of MKK4 in ovarian serous carcinoma
    Cancer Biol Ther, 5 (6), 630-4
    PubMed 16627982
14. Nakayama K, Nakayama N, Davidson B, Sheu JJ, Jinawath N, Santillan A, Salani R, Bristow RE, Morin PJ, Kurman RJ, Wang TL, Shih IeM (2006)
    A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival
    Proc Natl Acad Sci U S A, 103 (49), 18739-44
    PubMed 17130457
15. Park JT, Li M, Nakayama K, Mao TL, Davidson B, Zhang Z, Kurman RJ, Eberhart CG, Shih IeM, Wang TL (2006)
    Notch3 gene amplification in ovarian cancer
    Cancer Res, 66 (12), 6312-8
    PubMed 16778208
16. Rocha AS, Risberg B, Magalhães J, Trovisco V, de Castro IV, Lazarovici P, Soares P, Davidson B, Sobrinho-Simões M (2006)
    The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma
    Hum Pathol, 37 (5), 562-8
    PubMed 16647954
17. Sivertsen S, Berner A, Michael CW, Bedrossian C, Davidson B (2006)
    Cadherin expression in ovarian carcinoma and malignant mesothelioma cell effusions
    Acta Cytol, 50 (6), 603-7
    PubMed 17152269
18. Sivertsen S, Hadar R, Elloul S, Vintman L, Bedrossian C, Reich R, Davidson B (2006)
    Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression
    Lung Cancer, 54 (3), 309-17
    PubMed 16996643
19. Ødegaard E, Staff AC, Kaern J, Flørenes VA, Kopolovic J, Tropé CG, Abeler VM, Reich R, Davidson B (2006)
    The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma
    Gynecol Oncol, 100 (3), 462-8
    PubMed 16216317

Publications 2005

1. Chen YC, Davidson B, Cheng CC, Maitra A, Giuntoli RL, Hruban RH, Wang TL, Shih IeM (2005)
   Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma
   Biochim Biophys Acta, 1730 (2), 96-102
   PubMed 16084606
2. Chen YC, Pohl G, Wang TL, Morin PJ, Risberg B, Kristensen GB, Yu A, Davidson B, Shih IeM (2005)
   Apolipoprotein E is required for cell proliferation and survival in ovarian cancer
   Cancer Res, 65 (1), 331-7
   PubMed 15665311
3. Davidson B, Abeler VM (2005)
   Primary ovarian angiosarcoma presenting as malignant cells in ascites: case report and review of the literature
   Diagn Cytopathol, 32 (5), 307-9
   PubMed 15830366
4. Davidson B, Elstrand MB, McMaster MT, Berner A, Kurman RJ, Risberg B, Trope CG, Shih IeM (2005)
   HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma
   Gynecol Oncol, 96 (1), 42-7
   PubMed 15589578
5. Davidson B, Vintman L, Nielsen S, Reich R, Berner A (2005)
   Site-related expression of metastasis-associated and signaling molecules in malignant mesothelioma--a new model for the study of tumor biology and disease progression
   Lung Cancer, 49 Suppl 1, S89-93
   PubMed 15950809
6. Davidson B, Xi Z, Klokk TI, Tropé CG, Dørum A, Scheistrøen M, Saatcioglu F (2005)
   Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions
   Am J Clin Pathol, 123 (3), 360-8
   PubMed 15716231
7. Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B (2005)
   Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma
   Cancer, 103 (8), 1631-43
   PubMed 15742334
8. Givant-Horwitz V, Davidson B, Reich R (2005)
   Laminin-induced signaling in tumor cells
   Cancer Lett, 223 (1), 1-10
   PubMed 15890231
9. Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B (2005)
   Angiogenic molecule expression is downregulated in effusions from breast cancer patients
   Breast Cancer Res Treat, 94 (1), 71-80
   PubMed 16142438
10. Reich R, Vintman L, Nielsen S, Kaern J, Bedrossian C, Berner A, Davidson B (2005)
    Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities
    Diagn Cytopathol, 33 (5), 332-7
    PubMed 16240397
11. Schaner ME, Davidson B, Skrede M, Reich R, Flørenes VA, Risberg B, Berner A, Goldberg I, Givant-Horwitz V, Tropè CG, Kristensen GB, Nesland JM, Børresen-Dale AL (2005)
    Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
    Mol Cancer, 4, 26
    PubMed 16042759
12. Shih IeM, Sheu JJ, Santillan A, Nakayama K, Yen MJ, Bristow RE, Vang R, Parmigiani G, Kurman RJ, Trope CG, Davidson B, Wang TL (2005)
    Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma
    Proc Natl Acad Sci U S A, 102 (39), 14004-9
    PubMed 16172393
13. Sigstad E, Dong HP, Nielsen S, Berner A, Davidson B, Risberg B (2005)
    Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping
    Diagn Cytopathol, 33 (5), 325-31
    PubMed 16240402
14. Slipicevic A, Holm R, Nguyen MT, Bøhler PJ, Davidson B, Flørenes VA (2005)
    Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome
    Am J Clin Pathol, 124 (4), 528-36
    PubMed 16146807
15. Stevens EV, Raffeld M, Espina V, Kristensen GB, Trope' CG, Kohn EC, Davidson B (2005)
    Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma
    Cancer, 103 (11), 2313-9
    PubMed 15844177
16. Sudbø J, Samuelsson R, Risberg B, Heistein S, Nyhus C, Samuelsson M, Puntervold R, Sigstad E, Davidson B, Reith A, Berner A (2005)
    Risk markers of oral cancer in clinically normal mucosa as an aid in smoking cessation counseling
    J Clin Oncol, 23 (9), 1927-33 (Retracted)
    PubMed 15774785
17. Vintman L, Nielsen S, Berner A, Reich R, Davidson B (2005)
    Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells
    Cancer, 103 (11), 2427-33
    PubMed 15830375

Publications 2004

1. Davidson B (2004)
   Malignant effusions: from diagnosis to biology
   Diagn Cytopathol, 31 (4), 246-54
   PubMed 15452897
2. Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC (2004)
   Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma
   Cancer, 100 (10), 2139-47
   PubMed 15139056
3. Davidson B, Goldberg I, Tell L, Vigdorchik S, Baekelandt M, Berner A, Kristensen GB, Reich R, Kopolovic J (2004)
   The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions
   Clin Exp Metastasis, 21 (3), 191-9
   PubMed 15387369
4. Davidson B, Konstantinovsky S, Nielsen S, Dong HP, Berner A, Vyberg M, Reich R (2004)
   Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression
   Clin Cancer Res, 10 (21), 7335-46
   PubMed 15534110
5. Davidson B, Reich R, Lazarovici P, Ann Flørenes V, Nielsen S, Nesland JM (2004)
   Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma
   Breast Cancer Res Treat, 83 (2), 119-28
   PubMed 14997042
6. Davidson B, Reich R, Lazarovici P, Flørenes VA, Risberg B, Nielsen S, Sert B, Bedrossian C (2004)
   Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma
   Lung Cancer, 44 (2), 159-65
   PubMed 15084380
7. Davidson B, Suo Z, Nesland JM (2004)
   Malignant mesothelioma
   Ultrastruct Pathol, 28 (4), 179-80
   PubMed 15693629
8. Davidson B, Vintman L, Zcharia E, Bedrossian C, Berner A, Nielsen S, Ilan N, Vlodavsky I, Reich R (2004)
   Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma
   Clin Exp Metastasis, 21 (5), 469-76
   PubMed 15672872
9. Flørenes VA, Maelandsmo GM, Holm R, Reich R, Lazarovici P, Davidson B (2004)
   Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome
   Am J Clin Pathol, 122 (3), 412-20
   PubMed 15362372
10. Givant-Horwitz V, Davidson B, Goderstad JM, Nesland JM, Tropé CG, Reich R (2004)
    The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma
    Gynecol Oncol, 93 (2), 517-23
    PubMed 15099972
11. Givant-Horwitz V, Davidson B, Reich R (2004)
    Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor
    Cancer Res, 64 (10), 3572-9
    PubMed 15150114
12. Posadas EM, Davidson B, Kohn EC (2004)
    Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature
    Curr Opin Oncol, 16 (5), 478-84
    PubMed 15314519
13. Sigstad E, Dong HP, Davidson B, Berner A, Tierens A, Risberg B (2004)
    The role of flow cytometric immunophenotyping in improving the diagnostic accuracy in referred fine-needle aspiration specimens
    Diagn Cytopathol, 31 (3), 159-63
    PubMed 15349984
14. Stevens EV, Posadas EM, Davidson B, Kohn EC (2004)
    Proteomics in cancer
    Ann Oncol, 15 Suppl 4, iv167-71
    PubMed 15477302
15. Xi Z, Kaern J, Davidson B, Klokk TI, Risberg B, Tropé C, Saatcioglu F (2004)
    Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer
    Gynecol Oncol, 94 (1), 80-5
    PubMed 15262123

Publications 2003

1. Berner A, Davidson B, Sigstad E, Risberg B (2003)
   Fine-needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions
   Diagn Cytopathol, 29 (6), 344-8
   PubMed 14648793
2. Davidson B, Givant-Horwitz V, Lazarovici P, Risberg B, Nesland JM, Trope CG, Schaefer E, Reich R (2003)
   Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma
   Clin Exp Metastasis, 20 (7), 621-31
   PubMed 14669793
3. Davidson B, Goldberg I, Berner A, Kristensen GB, Reich R (2003)
   EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma
   Clin Exp Metastasis, 20 (2), 161-9
   PubMed 12705637
4. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Reich R (2003)
   PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma
   Clin Cancer Res, 9 (4), 1412-9
   PubMed 12684413
5. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Risberg B, Ben-Baruch G, Reich R (2003)
   Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?
   Cancer Metastasis Rev, 22 (1), 103-15
   PubMed 12716042
6. Davidson B, Goldberg I, Reich R, Tell L, Dong HP, Trope' CG, Risberg B, Kopolovic J (2003)
   AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients
   Gynecol Oncol, 90 (2), 248-57
   PubMed 12893184
7. Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, Tropé CG, Flørenes VA (2003)
   Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma
   Clin Cancer Res, 9 (6), 2248-59
   PubMed 12796393
8. Davidson B, Risberg B, Reich R, Berner A (2003)
   Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis
   Clin Lab Med, 23 (3), 729-54, viii
   PubMed 14560537
9. Givant-Horwitz V, Davidson B, Lazarovici P, Schaefer E, Nesland JM, Tropé CG, Reich R (2003)
   Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions
   Gynecol Oncol, 91 (1), 160-72
   PubMed 14529677
10. Givant-Horwitz V, Davidson B, van de Putte G, Dong HP, Goldberg I, Amir S, Kristensen GB, Reich R (2003)
    Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma
    Clin Exp Metastasis, 20 (7), 599-609
    PubMed 14669791
11. Sudbø J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Søland TM, Lippman SM (2003)
    Molecular based treatment of oral cancer
    Oral Oncol, 39 (8), 749-58 (Retracted)
    PubMed 13679198

Publications 2002

1. Davidson B, Dong HP, Berner A, Christensen J, Nielsen S, Johansen P, Bryne M, Asschenfeldt P, Risberg B (2002)
   Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases
   Am J Clin Pathol, 118 (1), 85-92
   PubMed 12109861
2. Davidson B, Goldberg I, Givant-Horwitz V, Nesland JM, Berner A, Bryne M, Risberg B, Kopolovic J, Kristensen GB, Tropé CG, van de Putte G, Reich R (2002)
   Caveolin-1 expression in ovarian carcinoma is MDR1 independent
   Am J Clin Pathol, 117 (2), 225-34
   PubMed 11863219
3. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Reich R (2002)
   The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma
   Mol Cell Endocrinol, 187 (1-2), 39-45
   PubMed 11988310
4. Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, Tropé CG, Bryne M, Risberg B, van de Putte G, Goldberg I (2002)
   Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions
   Clin Exp Metastasis, 19 (2), 135-44
   PubMed 11964077
5. Davidson B, Reich R, Risberg B, Nesland JM (2002)
   The biological role and regulation of matrix metalloproteinases (MMP) in cancer
   Arkh Patol, 64 (3), 47-53
   PubMed 15338725
6. Karbova E, Davidson B, Metodiev K, Tropé CG, Nesland JM (2002)
   Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma
   Int J Surg Pathol, 10 (3), 175-80
   PubMed 12232570
7. Risberg B, Karlsson K, Abeler V, Lagrelius A, Davidson B, Karlsson MG (2002)
   Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications
   Int J Gynecol Pathol, 21 (2), 155-60
   PubMed 11917225
8. Ustün M, Berner A, Davidson B, Risberg B (2002)
   Fine-needle aspiration cytology of lobular carcinoma in situ
   Diagn Cytopathol, 27 (1), 22-6
   PubMed 12112810
9. Ustün M, Risberg B, Davidson B, Berner A (2002)
   Cystic change in metastatic lymph nodes: a common diagnostic pitfall in fine-needle aspiration cytology
   Diagn Cytopathol, 27 (6), 387-92
   PubMed 12451573

Publications 2001

1. Amitay R, Nass D, Meitar D, Goldberg I, Davidson B, Trakhtenbrot L, Brok-Simoni F, Ben-Ze'ev A, Rechavi G, Kaufmann Y (2001)
   Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma
   Am J Pathol, 159 (1), 43-9
   PubMed 11438452
2. Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G (2001)
   Infertility treatment after conservative management of borderline ovarian tumors
   Cancer, 92 (2), 320-5
   PubMed 11466685
3. Davidson B (2001)
   Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature
   Anal Cell Pathol, 23 (3-4), 107-28
   PubMed 12082292
4. Davidson B, Goldberg I, Berner A, Nesland JM, Givant-Horwitz V, Bryne M, Risberg B, Kristensen GB, Tropé CG, Kopolovic J, Reich R (2001)
   Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions
   Am J Clin Pathol, 115 (4), 517-24
   PubMed 11293899
5. Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R (2001)
   Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients
   Clin Cancer Res, 7 (11), 3457-64
   PubMed 11705863
6. Davidson B, Nesland JM, Goldberg I, Kopolovic J, Gotlieb WH, Bryne M, Ben-Baruch G, Berner A, Reich R (2001)
   Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic study
   Gynecol Oncol, 81 (2), 166-71
   PubMed 11330944
7. Davidson B, Nielsen S, Christensen J, Asschenfeldt P, Berner A, Risberg B, Johansen P (2001)
   The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells
   Am J Surg Pathol, 25 (11), 1405-12
   PubMed 11684957
8. Davidson B, Reich R, Berner A, Givant-Horwitz V, Goldberg I, Risberg B, Kristensen GB, Trope CG, Bryne M, Kopolovic J, Nesland JM (2001)
   Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
   Eur J Cancer, 37 (16), 2040-9
   PubMed 11597382
9. Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM (2001)
   Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma
   Clin Cancer Res, 7 (3), 551-7
   PubMed 11297247
10. Davidson B, Risberg B, Berner A, Nesland JM, Tropé CG, Kristensen GB, Bryne M, Goscinski M, van de Putte G, Flørenes VA (2001)
    Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications
    Gynecol Oncol, 83 (2), 249-56
    PubMed 11606079
11. Davidson B, Risberg B, Goldberg I, Nesland JM, Berner A, Tropé CG, Kristensen GB, Bryne M, Reich R (2001)
    Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome
    Am J Surg Pathol, 25 (12), 1493-500
    PubMed 11717538
12. Goldberg I, Davidson B, Reich R, Gotlieb WH, Ben-Baruch G, Bryne M, Berner A, Nesland JM, Kopolovic J (2001)
    Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma
    Clin Cancer Res, 7 (12), 4073-9
    PubMed 11751504
13. Gotlieb WH, Goldberg I, Weisz B, Davidson B, Novikov I, Kopolovic J, Ben-Baruch G (2001)
    Topoisomerase II immunostaining as a prognostic marker for survival in ovarian cancer
    Gynecol Oncol, 82 (1), 99-104
    PubMed 11426969
14. Risberg B, Davidson B, Nielsen S, Dong HP, Christensen J, Johansen P, Asschenfeldt P, Berner A (2001)
    Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry
    Diagn Cytopathol, 25 (4), 214-9
    PubMed 11599103

Publications 2000

1. Berner HS, Davidson B, Berner A, Risberg B, Kristensen GB, Trope CG, Van de Putte G, Nesland JM (2000)
   Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications
   Clin Exp Metastasis, 18 (2), 197-202
   PubMed 11235996
2. Berner HS, Davidson B, Berner A, Risberg B, Nesland JM (2000)
   Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions
   Virchows Arch, 436 (4), 330-5
   PubMed 10834535
3. Cohen ZR, Knoller N, Hadani M, Davidson B, Nass D, Ram Z (2000)
   Traumatic intratumoral hemorrhage as the presenting symptom of a spinal neurinoma. Case report
   J Neurosurg, 93 (2 Suppl), 327-9
   PubMed 11012070
4. Davidson B, Berner A (2000)
   [Serous effusions]
   Tidsskr Nor Laegeforen, 120 (3), 367-72
   PubMed 10827531
5. Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V (2000)
   E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions
   J Pathol, 192 (4), 460-9
   PubMed 11113863
6. Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M (2000)
   Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions
   Hum Pathol, 31 (9), 1081-7
   PubMed 11014575
7. Davidson B, Goldberg I, Kopolovic J, Gotlieb WH, Givant-Horwitz V, Nesland JM, Berner A, Ben-Baruch G, Bryne M, Reich R (2000)
   Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study
   Clin Exp Metastasis, 18 (6), 501-7
   PubMed 11592307
8. Davidson B, Goldberg I, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Novikov I, Kopolovic J (2000)
   Expression of topoisomerase II and Ki-67 in cervical carcinoma--clinicopathological study using immunohistochemistry
   APMIS, 108 (3), 209-15
   PubMed 10752690
9. Davidson B, Gotlieb WH, Ben-Baruch G, Kopolovic J, Goldberg I, Nesland JM, Berner A, Bjåmer A, Bryne M (2000)
   Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study
   Gynecol Oncol, 77 (1), 35-43
   PubMed 10739688
10. Davidson B, Gotlieb WH, Ben-Baruch G, Nesland JM, Bryne M, Goldberg I, Kopolovic J, Berner A (2000)
    E-Cadherin complex protein expression and survival in ovarian carcinoma
    Gynecol Oncol, 79 (3), 362-71
    PubMed 11104606
11. Gotlieb WH, Soriano D, Achiron R, Zalel Y, Davidson B, Kopolovic J, Novikov I, Ben-Baruch G (2000)
    CA 125 measurement and ultrasonography in borderline tumors of the ovary
    Am J Obstet Gynecol, 183 (3), 541-6
    PubMed 10992171
12. Risberg B, Davidson B, Dong HP, Nesland JM, Berner A (2000)
    Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings
    J Clin Pathol, 53 (7), 513-7
    PubMed 10961174
13. Teixeira R, Pastacaldi S, Davies S, Dhillon AP, Emery VC, Rolles K, Davidson B, Patch D, Burroughs AK (2000)
    The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation
    Transplantation, 70 (10), 1454-8
    PubMed 11118089

Publications 1999

1. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Berner A, Bryne M, Reich R (1999)
   High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma
   Clin Exp Metastasis, 17 (10), 799-808
   PubMed 11089877
2. Davidson B, Goldberg I, Gotlieb WH, Lerner-Geva L, Ben-Baruch G, Agulansky L, Novikov I, Kopolovic J (1999)
   Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma--clinicopathologic correlation
   Acta Obstet Gynecol Scand, 78 (3), 240-4
   PubMed 10078587
3. Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Reich R (1999)
   MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
   Gynecol Oncol, 73 (3), 372-82
   PubMed 10366463
4. Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Weis B, Ben-Baruch G, Reich R (1999)
   Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
   Gynecol Oncol, 72 (3), 380-6
   PubMed 10053110
5. Davidson B, Risberg B, Berner A, Smeland EB, Torlakovic E (1999)
   Evaluation of lymphoid cell populations in cytology specimens using flow cytometry and polymerase chain reaction
   Diagn Mol Pathol, 8 (4), 183-8
   PubMed 10617274
6. Davidson B, Risberg B, Kristensen G, Kvalheim G, Emilsen E, Bjåmer A, Berner A (1999)
   Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers
   Virchows Arch, 435 (1), 43-9
   PubMed 10431845
7. Liokumovich P, Goldberg I, Davidson B, Gotlieb WH, Zahavi T, Ben-Baruch G, Reder I, Kopolovic J (1999)
   Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis
   J Clin Pathol, 52 (3), 198-202
   PubMed 10450179
8. Stratton R, Bryce K, Beynon H, Tibballs J, Watkinson A, Davidson B (1999)
   Systemic vasculitis with multiple aneurysms complicating systemic lupus erythematosus
   J R Soc Med, 92 (12), 636-7
   PubMed 10692887
9. Warwick RJ, Davidson B, Watkinson A (1999)
   Successful use of a covered nitinol self-expanding stent to seal a malignant fistula of the common bile duct
   Clin Radiol, 54 (6), 410-2
   PubMed 10406346

Publications 1998

1. Barshack I, Goldberg I, Davidson B, Ravid A, Schiby G, Kopolovic J, Leviav A, Friedman E (1998)
   Expression of rasGTPase activating protein in basal cell carcinoma of the skin
   Mod Pathol, 11 (3), 271-5
   PubMed 9521474
2. Davidson B, Agulansky L, Goldberg I, Friedman E, Ramon J, Barshack I, Kopolovic J (1998)
   Immunohistochemical analysis of rasGTPase activating protein (rasGAP) in prostate cancer
   Pathol Res Pract, 194 (6), 399-404
   PubMed 9689648
3. Davidson B, Goldberg I, Gotlieb WH, Ben-Baruch G, Kopolovic J (1998)
   CD44 expression in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study
   Eur J Gynaecol Oncol, 19 (1), 46-9
   PubMed 9476059
4. Davidson B, Goldberg I, Gotlieb WH, Ben-Baruch G, Kopolovic J (1998)
   Expression of matrix proteins in uterine cervical neoplasia using immunohistochemistry
   Eur J Obstet Gynecol Reprod Biol, 76 (1), 109-14
   PubMed 9481557
5. Davidson B, Goldberg I, Gotlieb WH, Lerner-Geva L, Ben-Baruch G, Kopolovic J (1998)
   Ulex Europaeus lectin and anti-CD31 staining in squamous cell carcinoma of the uterine cervix: potential prognostic markers
   Int J Gynecol Pathol, 17 (3), 205-10
   PubMed 9656115
6. Davidson B, Goldberg I, Liokumovich P, Kopolovic J, Gotlieb WH, Lerner-Geva L, Reder I, Ben-Baruch G, Reich R (1998)
   Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix
   Int J Gynecol Pathol, 17 (4), 295-301
   PubMed 9785129
7. Goldberg I, Davidson B, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Novikov I, Kopolovic J (1998)
   Expression of extracellular matrix proteins in cervical squamous cell carcinoma--a clinicopathological study
   J Clin Pathol, 51 (10), 781-5
   PubMed 10023343
8. Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G (1998)
   Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome
   Cancer, 82 (1), 141-6
   PubMed 9428490
9. Gotlieb WH, Friedman E, Bar-Sade RB, Kruglikova A, Hirsh-Yechezkel G, Modan B, Inbar M, Davidson B, Kopolovic J, Novikov I, Ben-Baruch G (1998)
   Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors
   J Natl Cancer Inst, 90 (13), 995-1000
   PubMed 9665148

Publications 1997

1. Davidson B, Goldberg I, Kopolovic J (1997)
   Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix
   Pathol Res Pract, 193 (7), 491-5
   PubMed 9342755
2. Davidson B, Goldberg I, Kopolovic J (1997)
   Angiogenesis in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study
   Int J Gynecol Pathol, 16 (4), 335-8
   PubMed 9421072
3. Davidson B, Nass D (1997)
   [Genetic defects in neurodegenerative diseases]
   Harefuah, 132 (7), 481-5
   PubMed 9153920
4. Salai M, Zemmer D, Segal E, Corat A, Heyman Z, Davidson B, Langevitz P, Livneh A (1997)
   Chronic massive knee effusion in familial Mediterranean fever
   Semin Arthritis Rheum, 27 (3), 169-72
   PubMed 9431588

Publications 1995

1. Davidson B, Kopolovic J (1995)
   [Molecular biology of human papilloma virus infection of the female genital tract]
   Harefuah, 129 (10), 417-20
   PubMed 8647548